BioStatus Limited develops fluorescent dyes and buffers that improve nuclear visualisation and segmentation in high-plex imaging experiments. Based in Shepshed, Leicestershire, the company created the DRAQ5, DRAQ7 and CyTRAK Orange stains that are routinely incorporated into multiplex immunofluorescence, imaging mass cytometry and high-content screening protocols.
Why researchers choose BioStatus products:
• Ready-to-use nuclear counterstains compatible with live, fixed, FFPE and fresh frozen material
• Reagents validated on Akoya, Leica, Zeiss and Yokogawa platforms to support single-cell segmentation and machine learning pipelines
• ISO 13485–aligned manufacturing with batch-specific QC data and technical support from UK scientists
Reagent packs ship worldwide from the UK HQ, with on-demand documentation to streamline spatial biology assay validation.